ArticleLeukemia & lymphoma2019

Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.

Rodica P Bunaciu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.